Range Biotechnologies is creating tools to enable personalized health through translational proteomics.
Range Biotechnologies has raised $5.2M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
Range Biotechnologies's investors include Pear VC, Civilization Ventures, Pillar VC, Artis Ventures, Four Cities Capital.
Range Biotechnologies is headquartered in San Carlos, United States.
Range Biotechnologies is creating tools to enable personalized health through translational proteomics.
Range Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Range Biotechnologies — Funding & Investors." VCBacked, June 12, 2023, https://www.vcbacked.co/company/range-biotechnologies. Accessed July 20, 2026.
VCBacked. (2023). Range Biotechnologies — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/range-biotechnologies
{{cite web |title=Range Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/range-biotechnologies |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated